Navigation Links
IOC Takes Decisive Action on Ticketing Allegations
Date:6/18/2012

(PRWEB) June 18, 2012

The International Olympic Committee (IOC) has moved quickly to deal with allegations that some National Olympic Committees (NOC) and Authorised Ticket Resellers (ATR) have broken rules relating to the sale of Olympic tickets.

After claims that several NOCs and ATRs were reportedly willing to break the rules by offering to buy or sell tickets outside their territory, sell tickets at inflated prices, or sell tickets to unauthorized resellers, the IOC has ordered an immediate inquiry and referred the allegations to its independent Ethics Commission.

On being informed of the allegations, the IOC immediately convened an extraordinary meeting of its Executive Board and determined a number of actions - the convening of the Ethics Commission and asking for any evidence of wrongdoing to be provided to the Commission without delay.

The IOC takes these allegations very seriously and has immediately taken the first steps to investigate. Should any irregularities be proven, the organisation will deal with those involved in an appropriate manner. The NOCs are autonomous organisations, but if any of the cases are confirmed the IOC will not hesitate to impose the strongest sanctions.

The IOC has also determined that it will take on board any recommendations coming out of the inquiry to improve the way that tickets are allocated and sold internationally in the future.

For more information, please contact the IOC Media Relations Team.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9614604.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Violence Takes a Toll on Childrens Sleep
2. Optogenetics project takes top NIDA Addiction Science Award
3. It takes a village to keep teens substance free
4. Study: Insomnia takes toll on tinnitus patients
5. CPAP found to improve sexual function, satisfaction in men with sleep apnea
6. States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds
7. Reactions to HIV drug have autoimmune cause, reports AIDS journal
8. Study Explores Distractions Role in Pain Relief
9. Driven to distraction
10. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: